Page last updated: 2024-10-20

pyrazinamide and Familial Hypokalemia-Hypomagnesemia

pyrazinamide has been researched along with Familial Hypokalemia-Hypomagnesemia in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"This features mimic Gitelman's syndrome which is an autosomal recessive disorder affecting kidneys causing electrolyte disturbances."1.56Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report. ( E R, V; Keny, S; Lawande, D; Parrikar, A, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
E R, V1
Parrikar, A1
Keny, S1
Lawande, D1

Other Studies

1 other study available for pyrazinamide and Familial Hypokalemia-Hypomagnesemia

ArticleYear
Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3

    Topics: Alkalosis; Antitubercular Agents; Capreomycin; Clofazimine; Cycloserine; Deprescriptions; Ethionamid

2020